Chief Growth Officer

Patty Obermaier serves as Chief Growth Officer, responsible for the company’s business development, marketing, and product management functions. She brings more than three decades of experience driving innovation, growth, and operational excellence across the health, life sciences, and technology sectors.

Obermaier has a proven track record of scaling global technology and services businesses to deliver financial success, execute high-impact transformations, and shape strategic outcomes that create value for organizations and improve the health of the people they serve. 

Obermaier held several senior leadership roles at Microsoft, most recently as CGO for Global Health and Life Sciences. In this role, she oversaw growth across a global $12 billion portfolio, led customer engagement strategies, and advanced Microsoft’s innovation agenda in emerging health technologies. She also played a pivotal role in integrating Nuance, Microsoft’s $20 billion acquisition, into the global field organization. Prior to this, she led Microsoft’s U.S. Health and Life Sciences business, where she doubled its growth from $3 billion to $6 billion. 

Earlier in her career, Obermaier founded and led Resigility, a consulting firm focused on performance transformation, resiliency, and growth strategies. She also spent more than five years at IQVIA as a senior executive leading the payer, provider, and government market businesses. Prior to that, she held several positions at Unisys. 

Obermaier currently serves on the Board of Directors of ASGN Incorporated (NYSE: ASGN) and Applied Information Sciences (AIS). She holds an MBA from the Darden School at the University of Virginia and a bachelor’s degree in biology from the Massachusetts Institute of Technology.